

Author: Satyanarayana Padi S.V.
Publisher: VSP
ISSN: 1568-5608
Source: Inflammopharmacology, Vol.12, Iss.1, 2004-02, pp. : 57-68
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content






By Shimada K. Kita T. Yonetani Y. Suzumura A. Takayanagi T. Nakashima T.
European Journal of Pharmacology, Vol. 376, Iss. 3, 1999-07 ,pp. :




Selective inhibitors of cyclooxygenase-2
By Talley J.J.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. :